Cargando…
Cannabidiol for the Treatment of Neonatal Hypoxic-Ischemic Brain Injury
Each year, more than two million babies die or evolve to permanent invalidating sequelae worldwide because of Hypoxic-Ischemic Brain Injury (HIBI). There is no current treatment for that condition except for therapeutic hypothermia, which benefits only a select group of newborns. Preclinical studies...
Autores principales: | Martínez-Orgado, José, Villa, María, del Pozo, Aarón |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7830676/ https://www.ncbi.nlm.nih.gov/pubmed/33505306 http://dx.doi.org/10.3389/fphar.2020.584533 |
Ejemplares similares
-
Role of 5HT1A Receptors in the Neuroprotective and Behavioral Effects of Cannabidiol in Hypoxic–Ischemic Newborn Piglets
por: Barata, Lorena, et al.
Publicado: (2022) -
Mood disorders in children following neonatal hypoxic-ischemic encephalopathy
por: Álvarez-García, María, et al.
Publicado: (2022) -
Diastolic Dysfunction in Neonates With Hypoxic-Ischemic Encephalopathy During Therapeutic Hypothermia: A Tissue Doppler Study
por: Rodriguez, Maria Jose, et al.
Publicado: (2022) -
Cannabidiol Administration Prevents Hypoxia-Ischemia-Induced Hypomyelination in Newborn Rats
por: Ceprián, María, et al.
Publicado: (2019) -
Cannabidiol Reduces Inflammatory Lung Damage After Meconium Aspiration in Newborn Piglets
por: Arruza, Luis, et al.
Publicado: (2022)